Pulse May 2019 issue - Page 24

MAX INTRODUCING Hi, I’m MAX and I want to tell you about DuoResp Spiromax, an inhaler for patients in the real world. One that: 1. Is ready to use with one fl ip of the cover 2. Delivers consistent dosing under real-world conditions* 1,2 3. Off ers the fl exibility of maintenance and reliever therapy (MART) in asthma** 3 Prescribe DuoResp Spiromax. For asthma and COPD in adults † duoresp.co.uk *Consistent dose delivery at flow rates of 30–90 L/min, 1,2 after storage at high temperature (-20°C to +40°C) and humidity (25% to 79%) and when inhaler orientation varied from + to -90 degrees from vertical. 2 Dose delivery study using low, middle and high strength DuoResp Spiromax. Dose consistency was measured over inhaler life. Low dose was included in the study but is not licensed in the UK. 2 **For 160/4.5mcg strength only. 3 † DuoResp Spiromax is licensed for use in adults 18 years of age and older only. 3 Prescribing information and adverse event reporting can be found overleaf.